Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Chaib I, Cai X, Llige D, Santarpia M, Jantus-Lewintre E, Filipska M, Pedraz C, Cui J, Yang J, Miao J, Sun R, Bracht JWP, Ito M, Codony-Servat J, Karachaliou N, Aguilar A, Rosell R, Cao P.
Chaib I, et al. Among authors: pedraz c.
Ann Transl Med. 2019 Nov;7(22):651. doi: 10.21037/atm.2019.10.80.
Ann Transl Med. 2019.
PMID: 31930052
Free PMC article.